NIPH logo

March

This content is archived and will not be updated.

Search only showing archived content

11 hits
  1. Norwegian Medicines Agency investigating notification about death

    Norwegian Medicines Agency investigating notification about death

    Last update

    The Norwegian Medicines Agency and the Norwegian Institute of Public Health (NIPH) have received a report of a death following vaccination with the AstraZeneca vaccine.
  2. Extended pause for AstraZeneca vaccine

    Extended pause for AstraZeneca vaccine

    Last update

    The Norwegian Institute of Public Health has decided to extend the pause in the use of the AstraZeneca vaccine because further investigations are necessary.
  3. AstraZeneca vaccine still on hold in Norway

    AstraZeneca vaccine still on hold in Norway

    Last update

    The Norwegian Institute of Public Health (NIPH) will keep use of the AstraZeneca vaccine on hold in Norway and will continue a thorough review of the situation. An update will be provided at the end of week 12.
  4. UK virus variant associated with higher risk of hospital admission

    UK virus variant associated with higher risk of hospital admission

    Last update

    The UK variant of the coronavirus is associated with a higher risk of being admitted to hospital, even among young adults, according to a new study from the Norwegian Institute of Public Health.
    Sykehusseng
  5. AstraZeneca vaccine: When to consult a doctor

    AstraZeneca vaccine: When to consult a doctor

    Last update

    An overview of common side effects after AstraZeneca vaccination, and what people should be alert for, is released by the Norwegian Medicines Agency and the Norwegian Institute of Public Health.
  6. Norwegian Medicines Agency investigating notification about death

    Norwegian Medicines Agency investigating notification about death

    Last update

    The Norwegian Medicines Agency and the Norwegian Institute of Public Health (NIPH) have received a report of a death following vaccination with the AstraZeneca vaccine.
  7. AstraZeneca vaccine recommended for all over 18 years of age

    AstraZeneca vaccine recommended for all over 18 years of age

    Last update

    The Norwegian Institute of Public Health (NIPH) now recommends giving the coronavirus vaccine from AstraZeneca to people over the age of 18.
  8. Vaccination with AstraZeneca vaccine against COVID-19 put on hold

    Vaccination with AstraZeneca vaccine against COVID-19 put on hold

    Last update

    Following a report in Denmark of a death from a blood clot after receiving the AstraZeneca vaccine, Norway has chosen to suspend vaccination with the AstraZeneca vaccine.
  9. Changes in the vaccine strategy

    Changes in the vaccine strategy

    Last update

    The Norwegian Institute of Public Health will allocate more vaccine doses to areas at particular risk for infection and introduce a new distribution key for vaccines.
  10. See signs of protection against COVID-19 among those vaccinated

    See signs of protection against COVID-19 among those vaccinated

    Last update

    During the last five weeks, a sharp increase in transmission has been seen among most age groups in Norway, but not among the oldest who have the highest vaccination coverage.
  11. Norwegian Medicines Agency notified of blood clots and bleeding in younger people after vaccination with AstraZeneca vaccine

    Norwegian Medicines Agency notified of blood clots and bleeding in younger people after vaccination with AstraZeneca vaccine

    Last update

    The Norwegian Medicine Agency is asking people who had the AstraZeneca vaccine in the last 14 days and who feel increasingly unwell to be alert.